OTC Markets OTCPK - Delayed Quote USD

Mydecine Innovations Group Inc. (MYCOF)

0.0030

-0.0004

(-11.76%)

At close: May 16 at 4:00:00 PM EDT

Key Events

Advanced Chart

Loading Chart for MYCOF

Previous Close 0.0034
Open 0.0034
Bid 0.0027 x --
Ask 0.0090 x --
Day's Range 0.0034 - 0.0034
52 Week Range 0.0010 - 0.0160
Volume 100
Avg. Volume 11,053
Market Cap (intraday) 195,219
Beta (5Y Monthly) 3.71
PE Ratio (TTM) --
EPS (TTM) -0.1400
Earnings Date Jun 30, 2025 - Jul 4, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. Its lead product drug candidates include MYCO-005. The company also develops MYCO-006 and MYCO-007. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

www.mydecine.com

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MYCOF

0.00%

S&P/TSX Composite index (^GSPTSE)

5.49%

1-Year Return

MYCOF

70.00%

S&P/TSX Composite index (^GSPTSE)

16.47%

3-Year Return

MYCOF

99.70%

S&P/TSX Composite index (^GSPTSE)

28.53%

5-Year Return

MYCOF

99.19%

S&P/TSX Composite index (^GSPTSE)

77.42%

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MYCOF

Mydecine Innovations Group Inc.

0.0030

-11.76%

Mkt Cap 195,219